AAIM
PFE icon

Asset Advisors Investment Management’s Pfizer PFE Stock Holding History

Asset Advisors Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,502
Closed -$304K – 108
2024
Q3 		$304K Sell
10,502
-4,060
-28% -$118K 0.03% 95
2024
Q2 		$407K Sell
14,562
-5,685
-28% -$157K 0.04% 87
2024
Q1 		$562K Sell
20,247
-51,568
-72% -$1.43M 0.06% 73
2023
Q4 		$2.07M Sell
71,815
-10,448
-13% -$316K 0.25% 56
2023
Q3 		$2.73M Sell
82,263
-6,837
-8% -$242K 0.37% 48
2023
Q2 		$3.27M Sell
89,100
-3,500
-4% -$136K 0.42% 49
2023
Q1 		$3.78M Sell
92,600
-64,031
-41% -$2.77M 0.49% 48
2022
Q4 		$8.03M Sell
156,631
-400
-0.3% -$19.2K 1.06% 29
2022
Q3 		$6.87M Sell
157,031
-1,600
-1% -$77.7K 0.98% 29
2022
Q2 		$8.32M Sell
158,631
-2,450
-2% -$125K 1.13% 26
2022
Q1 		$8.34M Buy
161,081
+2,176
+1% +$113K 0.93% 31
2021
Q4 		$9.38M Buy
158,905
+5,309
+3% +$263K 0.95% 31
2021
Q3 		$6.61M Buy
153,596
+5,771
+4% +$256K 0.74% 36
2021
Q2 		$5.79M Buy
147,825
+3,207
+2% +$125K 0.64% 43
2021
Q1 		$5.29M Buy
144,618
+3,189
+2% +$113K 0.62% 43
2020
Q4 		$5.21M Buy
141,429
+13,926
+11% +$511K 0.67% 40
2020
Q3 		$4.44M Sell
127,503
-1,616
-1% -$56.7K 0.67% 39
2020
Q2 		$4.01M Buy
129,119
+4,268
+3% +$145K 0.64% 39
2020
Q1 		$3.87M Buy
124,851
+33,186
+36% +$1.13M 0.72% 38
2019
Q4 		$3.48M Buy
91,665
+21,384
+30% +$762K 0.51% 43
2019
Q3 		$2.4M Sell
70,281
-2,353
-3% -$85.6K 0.38% 48
2019
Q2 		$2.98M Buy
72,634
+1,775
+3% +$70.5K 0.5% 44
2019
Q1 		$2.85M Hold
70,859
– – 0.51% 46
2018
Q4 		$2.94M Sell
70,859
-1,581
-2% -$65.6K 0.58% 42
2018
Q3 		$3.03M Buy
+72,440
New +$2.79M 0.5% 46

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Asset Advisors Investment Management's PFE Position: Q4 2024 in Review

Asset Advisors Investment Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 10,502 shares — an estimated $304K sold.

Asset Advisors Investment Management first reported a position in PFE in Q3 2018 and held it in 25 quarters. The position peaked at $9.38M in Q4 2021. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Asset Advisors Investment Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Asset Advisors Investment Management sold 10,502 Pfizer shares in Q4 2024, an estimated $304K.
  • Asset Advisors Investment Management first reported a position in Pfizer in Q3 2018 and held it in 25 quarters.
  • Asset Advisors Investment Management's Pfizer position peaked at $9.38M in Q4 2021.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Asset Advisors Investment Management's 13F filing for Q4 2024, filed 4 Feb 2025.